1
|
Ashina H, Dodick DW, Barber J, Temkin NR, Chong CD, Adler JS, Stein KS, Schwedt TJ, Manley GT. Prevalence of and Risk Factors for Post-traumatic Headache in Civilian Patients After Mild Traumatic Brain Injury: A TRACK-TBI Study. Mayo Clin Proc 2023; 98:1515-1526. [PMID: 37480909 DOI: 10.1016/j.mayocp.2023.02.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Revised: 01/24/2023] [Accepted: 02/16/2023] [Indexed: 07/24/2023]
Abstract
OBJECTIVE To ascertain the prevalence of and risk factors for post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI). PATIENTS AND METHODS A prospective, longitudinal, multicenter cohort study of patients with mTBI and orthopedic trauma controls who were enrolled from February 26, 2014, to August 8, 2018. The baseline assessment was conducted as soon as possible following evaluation at the emergency department. Follow-ups were scheduled at 2 weeks, 3 months, 6 months, and 12 months postinjury. Eligible patients with mTBI included those 18 years of age or older who presented to the emergency department within 24 hours of head injury warranting evaluation by noncontrast head computed tomography scan. Acute PTH was considered present when a patient reported a headache score of greater than or equal to 2 on the Rivermead Post-concussion Questionnaire at 2 weeks postinjury (ie, headache is at least a mild problem compared with pre-injury). Persistent PTH was defined when a patient with acute PTH reported a Rivermead Post-concussion Questionnaire headache score of greater than or equal to 2 at the scheduled follow-up examinations. RESULTS Acute PTH was reported by 963 (60.4%) of 1594 patients with mTBI at 2 weeks postinjury. Among those with acute PTH, 439 (52.4%) of 837 patients reported persistent PTH at 3 months postinjury. This figure decreased over time and 278 (37.5%) of 742 patients continued to report persistent PTH at 6 months, whereas 187 (28.9%) of 646 patients did so as well at 12 months postinjury. Risk factors for acute PTH included younger age, female sex, fewer years of formal education, computed tomography-positive scans, alteration of consciousness, psychiatric history, and history of migraine. Risk factors for persistent PTH included female sex, fewer years of formal education, and history of migraine. CONCLUSION Post-traumatic headache is a prevalent sequela of mTBI that persists for at least 12 months in a considerable proportion of affected individuals. The attributable burden necessitates better patient follow-up, disease characterization, improved awareness of PTH in clinical practice, and identification of effective therapies.
Collapse
Affiliation(s)
- Håkan Ashina
- Danish Headache Center, Department of Neurology, Rigshospitalet, Faculty of Health and Medical Sciences and the Department of Neurorehabilitation and Traumatic Brain Injury, University of Copenhagen, Copenhagen, Denmark; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | | | - Jason Barber
- Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Nancy R Temkin
- Department of Neurological Surgery, University of Washington, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA
| | | | | | | | | | - Geoffrey T Manley
- Department of Neurological Surgery, University of California, San Francisco, California, USA.
| |
Collapse
|
2
|
Dhawan PS, Leong D, Tapsell L, Starling AJ, Galetta SL, Balcer LJ, Overall TL, Adler JS, Halker-Singh RB, Vargas BB, Dodick D. King-Devick Test identifies real-time concussion and asymptomatic concussion in youth athletes. Neurol Clin Pract 2017; 7:464-473. [PMID: 29431168 DOI: 10.1212/cpj.0000000000000381] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background Sports concussion has an annual incidence of approximately 3.8 million. Over half go unreported and a substantial number may be asymptomatic. A rapid, cost-effective, and reliable tool that facilitates diagnosis of concussion is needed. The King-Devick (K-D) test is a vision-based tool of rapid number naming for assessment of concussion. In this study, we evaluated the utility of the K-D test in real time for identification of symptomatic concussion in youth athletes and to determine if similar impairment (subclinical concussion) exists in youth athletes without an obvious head injury or symptoms. Methods Youth hockey players underwent K-D testing preseason, postseason, and immediately after suspected concussion. Additional testing was performed in a subgroup of nonconcussed athletes immediately before and after a game to determine effects of fatigue on K-D scores. Results Among 141 players tested, 20 had clinically diagnosed concussion. All 20 had immediate postconcussion K-D times >5 seconds from baseline (average 7.3 seconds) and all but 2 had worse postseason scores (46.4 seconds vs 52.4 seconds, p < 0.05, Wilcoxon signed rank test). Nonconcussed athletes saw minimal improvement postseason (43.9 seconds vs 42.1 seconds, p < 0.05) and 51 nonconcussed players assessed before and after a game revealed no significant time change as a result of fatigue. Conclusions Rapid number naming using the K-D test accurately identifies real-time, symptomatic concussion in youth athletes. Scores in concussed players may remain abnormal over time. Athletes should undergo preseason and postseason K-D testing, with additional evaluation real time to inform the assessment of suspected concussion. Classification of Evidence This study provides Class III evidence that the K-D test accurately identifies real-time concussions in youth athletes.
Collapse
Affiliation(s)
- Priya S Dhawan
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Danielle Leong
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Lisa Tapsell
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Amaal J Starling
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Steven L Galetta
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Laura J Balcer
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Trenton L Overall
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Jennifer S Adler
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Rashmi B Halker-Singh
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - Bert B Vargas
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| | - David Dodick
- Department of Neurology (PSD, LT, AJS, TLO, RBH-S, BBV, DD), Mayo Clinic Arizona, Phoenix; King-Devick Test, Inc. (DL), Oakbrook Terrace, IL; Departments of Neurology (SLG, LJB), Ophthalmology (SLG, LJB), and Population Health (LJB), New York University Langone Medical Center, New York; Departments of Neurology (SLG, LJB) and Biostatistics and Epidemiology (LJB), University of Pennsylvania School of Medicine, Philadelphia; and University of Arizona (JSA), Scottsdale
| |
Collapse
|
3
|
Lin TP, Rigby H, Adler JS, Hentz JG, Balcer LJ, Galetta SL, Devick S, Cronin R, Adler CH. Abnormal visual contrast acuity in Parkinson's disease. J Parkinsons Dis 2015; 5:125-30. [PMID: 25425583 DOI: 10.3233/jpd-140470] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Low-contrast vision is thought to be reduced in Parkinson's disease (PD). This may have a direct impact on quality of life such as driving, using tools, finding objects, and mobility in low-light condition. Low-contrast letter acuity testing has been successful in assessing low-contrast vision in multiple sclerosis. We report the use of a new iPad application to measure low-contrast acuity in patients with PD. OBJECTIVE To evaluate low- and high-contrast letter acuity in PD patients and controls using a variable contrast acuity eye chart developed for the Apple iPad. METHODS Thirty-two PD and 71 control subjects were studied. Subjects viewed the Variable Contrast Acuity Chart on an iPad with both eyes open at two distances (40 cm and 2 m) and at high contrast (black and white visual acuity) and 2.5% low contrast. Acuity scores for the two groups were compared. RESULTS PD patients had significantly lower scores (indicating worse vision) for 2.5% low contrast at both distances and for high contrast at 2 m (p < 0.003) compared to controls. No significant difference was found between the two groups for high contrast at 40 cm (p = 0.12). CONCLUSIONS Parkinson's disease patients have reduced low and high contrast acuity compared to controls. An iPad app, as used in this study, could serve as a quick screening tool to complement more formal testing of patients with PD and other neurologic disorders.
Collapse
Affiliation(s)
- Tanya P Lin
- Department of Neurology, University of Arizona, Tucson, AZ, USA
| | - Heather Rigby
- Department of Neurology, Dalhousie University, Halifax, NS, Canada
| | | | - Joseph G Hentz
- Department of Biostatistics, Mayo Clinic College of Medicine, Scottsdale, AZ, USA
| | - Laura J Balcer
- Department of Neurology, NYU School of Medicine, New York, NY, USA
| | - Steven L Galetta
- Department of Neurology, NYU School of Medicine, New York, NY, USA
| | | | | | - Charles H Adler
- Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, AZ, USA
| |
Collapse
|